CD274 and non-small cell lung carcinoma: Another study [38] illustrated that a novel 18 mutated genes score 18 (TMS18) (HR 0.307, P < 0.001) had smaller HR and P value than PD-L1 expression (HR 0.403, P = 0.005) in survival analysis in 240 NSCLC patients.